These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1175 related articles for article (PubMed ID: 19397464)

  • 1. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy.
    Trotman RL; Williamson JC; Shoemaker DM; Salzer WL
    Clin Infect Dis; 2005 Oct; 41(8):1159-66. PubMed ID: 16163635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis.
    Rauf AA; Long KH; Gajic O; Anderson SS; Swaminathan L; Albright RC
    J Intensive Care Med; 2008; 23(3):195-203. PubMed ID: 18474503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update.
    Hoff BM; Maker JH; Dager WE; Heintz BH
    Ann Pharmacother; 2020 Jan; 54(1):43-55. PubMed ID: 31342772
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic evaluation of continuous renal replacement therapy in acute renal failure.
    Klarenbach S; Manns B; Pannu N; Clement FM; Wiebe N; Tonelli M;
    Int J Technol Assess Health Care; 2009 Jul; 25(3):331-8. PubMed ID: 19619352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug dosing in continuous renal replacement therapy: general rules.
    Schetz M
    Curr Opin Crit Care; 2007 Dec; 13(6):645-51. PubMed ID: 17975384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Li WX; Chen HD; Wang XW; Zhao S; Chen XK; Zheng Y; Song Y
    Chin Med J (Engl); 2009 May; 122(9):1020-5. PubMed ID: 19493435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy.
    Eachempati SR; Wang JC; Hydo LJ; Shou J; Barie PS
    J Trauma; 2007 Nov; 63(5):987-93. PubMed ID: 17993940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
    Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival by dialysis modality in critically ill patients with acute kidney injury.
    Cho KC; Himmelfarb J; Paganini E; Ikizler TA; Soroko SH; Mehta RL; Chertow GM
    J Am Soc Nephrol; 2006 Nov; 17(11):3132-8. PubMed ID: 17021268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous renal replacement therapy in the treatment of acute renal failure: critical assessment is required.
    Himmelfarb J
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):385-9. PubMed ID: 17699438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug dosing during continuous renal replacement therapy.
    Churchwell MD; Mueller BA
    Semin Dial; 2009; 22(2):185-8. PubMed ID: 19426426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy.
    Tillman J
    Nurs Crit Care; 2009; 14(4):191-9. PubMed ID: 19531037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino Acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Btaiche IF; Mohammad RA; Alaniz C; Mueller BA
    Pharmacotherapy; 2008 May; 28(5):600-13. PubMed ID: 18447659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based renal replacement therapy for acute kidney injury.
    Zarbock A; Singbartl K; Kellum JA
    Minerva Anestesiol; 2009 Mar; 75(3):135-9. PubMed ID: 18475252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing pattern of renal replacement therapy in acute renal failure: current status and future directions.
    Schiffl H
    Eur J Med Res; 2006 Apr; 11(4):178-82. PubMed ID: 16720285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal replacement therapy in acute kidney injury: which method to use in the intensive care unit?
    Davenport A
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):529-36. PubMed ID: 18580008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of renal replacement therapy in critically ill patients with acute kidney injury.
    Bouman CS; Oudemans-van Straaten HM
    Curr Opin Crit Care; 2007 Dec; 13(6):656-61. PubMed ID: 17975386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study.
    Kielstein JT; Eugbers C; Bode-Boeger SM; Martens-Lobenhoffer J; Haller H; Joukhadar C; Traunmüller F; Knitsch W; Hafer C; Burkhardt O
    Nephrol Dial Transplant; 2010 May; 25(5):1537-41. PubMed ID: 20031929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.